טוען...
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc
c-Myc is a transcription factor that is constitutively and aberrantly expressed in over 70% of human cancers. Its direct inhibition has been shown to trigger rapid tumor regression in mice with only mild and fully reversible side effects, suggesting this to be a viable therapeutic strategy. Here we...
שמור ב:
| הוצא לאור ב: | Mol Cancer |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7780693/ https://ncbi.nlm.nih.gov/pubmed/33397405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-020-01291-6 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|